Showing 7111-7120 of 8468 results for "".
- EON Robotic Body Contouring Device Receives Additional FDA Clearance for Back and Thighshttps://practicaldermatology.com/news/eon-robotic-body-contouring-device-receives-additional-fda-clearance-for-back-and-thighs/2461629/EON Smarter Body Contouring has received FDA clearance for the back and thighs—the third FDA clearance for EON. The device was previously FDA-cleared for clinical providers to treat patients' full abdomen and flanks. Parent company Dominion Aesthetic Technologies describe
- Burt's Bees Products Improve Redness, Pigmentation, and Reduce Acne-related PIHhttps://practicaldermatology.com/news/burts-bees-products-improve-redness-pigmentation-and-reduce-acne-related-pih/2461624/Burt’s Bees topical bakuchiol-containing sunscreen treats redness and pigmentation of photodamaged facial skin. What’s more, a cream containing Glycyrrhiza glabra (licorice root), Curcuma longa (turmeric root), and Terminalia chebula improves&n
- Galderma's IL-31 Blocker Nemolizumab Wows in PNhttps://practicaldermatology.com/news/galdermas-il-31-blocker-nemolizumab-wows-in-pn/2461619/Galderma’s nemolizumab performed well in Prurigo Nodularis (PN). Nemolizumab is a first-in-class investigational monoclonal antibody directed against the IL-31 receptor alpha that blocks signaling from IL-31.Nemolizumab is an investigational drug and Galderma has not received
- Dermatologist Terrence A. Cronin Jr., MD, Named New AAD Presidenthttps://practicaldermatology.com/news/dermatologist-terrence-a-cronin-jr-md-named-new-aad-president/2461615/Terrence A. Cronin Jr., MD, FAAD, is the new President of the American Academy of Dermatology. He will start his one-year term at the close of the Academy's Annual Meeting. Dr. Cronin will also hold the same position for the American Academy of Dermatology Association, a sister
- Phase 3 Data: Dermavant's VTAMA Cream Performs Well in Adults and Kids with ADhttps://practicaldermatology.com/news/dermavant-vtama-cream-in-adults-and-kids-with-ad/2461612/Dermavant’s VTAMA (tapinarof) performed well in kids as young as 2 and adults with atopic dermatitis, according to topline results from the ADORING 2 Atopic Dermatitis Phase 3 Trial. VTAMA cream is a novel, aryl hydrocarbon receptor agonist, in development as a once-dai
- Bioelectric V.Dox Technology Reduces Biofilm Infection in Burn Woundshttps://practicaldermatology.com/news/bioelectric-vdox-technology-reduces-biofilm-infection-in-burn-wounds/2461611/Vomaris Innovations, Inc. bioelectric V.Dox Technology prevents and reduces biofilm infection in burn wounds, a new study shows. The study appears in Advances in Wound Care. The collaborative research was led by Rodney Chan, M.D, a plastic and reco
- Cetaphil Celebrates Sensitive Skin with a Month of Skin Science Educationhttps://practicaldermatology.com/news/cetaphil-celebrates-sensitive-skin-with-a-month-of-skin-science-education/2461610/Cetaphil is ringing in the 2nd Annual Sensitive Skin Awareness initiative globally with a month of skin science education. Activating under the brand's campaign, "We Do Skin. You Do You," the global science effort will arm consumers with guidance on how to i
- BTL Cares Scholarship Winners Announcedhttps://practicaldermatology.com/news/btl-cares-scholarship-winners-announced/2461601/BTL Industries, along with professional golfer Michelle Wie West, have announced the winners of the second annual BTL Cares Scholar Draft. The program awards five student-athletes a $15,000 grant for tuition and college fees. The Scholar Draft aims to empow
- Ribon Therapeutics: First Patient Dosed in Phase 1 Study with RBN-3143 of ADhttps://practicaldermatology.com/news/ribon-therapeutics-first-patient-dosed-in-phase-1-study-with-rbn-3143-of-ad/2461599/Ribon Therapeutics dosed the first patient with RBN-3143 in the open-label cohort of patients with moderate-to-severe atopic dermatitis. The study aims to measure the pharmacodynamic activity of RBN-3143 and evaluate the safety and preliminary efficacy of 28 days of administration of RBN-3143 in
- PCA Skin Rings in the Fourth Annual National Peel Dayhttps://practicaldermatology.com/news/pca-skin-rings-in-the-fourth-annual-national-peel-day/2461598/March 10, 2023 is the fourth annual National Peel Day, created by PCA SKIN. "National Peel Day was established in 2020 to drive awareness, increase education, and demystify misconceptions around the non-invasive treatment,” says Joanna Zucker, CEO CP Skin Health Group US